Soborg, Denmark

Magali Zundel

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 60(Granted Patents)


Location History:

  • Soborg, DK (2004 - 2006)
  • Soeborg, DK (2008)
  • Dyssegaard, DK (2015)

Company Filing History:


Years Active: 2004-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Magali Zundel: A Pioneer in Enzyme-based Processes and Patents

Introduction:

Magali Zundel, a talented innovator hailing from Soborg, DK, has made significant contributions to the field of enzyme-based processes and patents. With a profound understanding of esterase activity and stereoselective hydrolysis, Zundel has developed groundbreaking technologies backed by his impressive portfolio of patents. Let's delve into his latest discoveries, highlights from his career, notable collaborations, and the significance of his advancements.

Latest Patents:

Zundel's recent patents showcase his expertise in the field of esterase enzymes and their applications:

1. Esterase Isolated from [object Object]:

This patented invention involves an esterase isolated from unknown sources capable of stereoselective hydrolysis of chiral esters. Additionally, it exhibits arylesterase (EC 3.1.1.2) and feruloyl esterase (EC 3.1.1.73) activities. The uniqueness of this esterase lies in its limited homology to known amino acid sequences, suggesting a novel enzyme with remarkable properties.

2. Process for the Preparation of Substituted 3-Phenyl-propanoic Acid Esters and Substituted 3-Phenyl-propanoic Acids:

This patented process focuses on the hydrolysis or trans esterification reactions of enantiomeric esters. By utilizing an enzyme that exhibits higher reactivity towards one enantiomeric form, the process achieves increased enantiomeric purity in both the resulting ester and acid products. This breakthrough technology presents new possibilities for synthesizing chiral compounds with improved efficiency.

Career Highlights:

Magali Zundel's career thrives on innovation and inventive solutions. Notable highlights include his tenure at renowned companies such as Novozymes A/S and Novo Nordisk Pharmaceuticals, Inc. These organizations provided Zundel with a conducive environment for research and development, allowing him to make significant breakthroughs in enzyme-based processes and applications.

Collaborations:

Collaboration plays a crucial role in fostering innovation, and Zundel understands this well. Throughout his career, he has worked closely with esteemed coworkers, including Heinz-Josef Deussen and Soren Ebdrup. These collaborations have proven instrumental in advancing the boundaries of esterase-based technologies and expanding the potential applications of his inventions.

Conclusion:

Magali Zundel's inventive prowess in the field of esterase enzymes and their applications has led to the development of revolutionary patent-backed technologies. His latest patents demonstrate his dedication to improving the synthesis of chiral compounds and furthering the understanding of enzyme-mediated processes. Zundel's collaboration with esteemed peers and his contributions at prominent companies like Novozymes and Novo Nordisk Pharmaceuticals underscores his remarkable contributions to the field. As the world of innovation and patents evolves, Magali Zundel's impact in enzyme-based processes will continue to shape the landscape of scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…